Ursolic acid is a triterpene plant extract that exhibits significant potential as an anti-cancer, anti-tumour, and anti-inflammatory agent. Its direct use in the pharmaceutical industry is hampered by poor uptake of ursolic acid in the human body coupled with rapid metabolism causing a decrease in bioactivity. Modification of ursolic acid can overcome such issues, however, use of toxic reagents, unsustainable synthetic routes and poor reaction metrics have limited its potential.
View Article and Find Full Text PDFHighly effective acid-catalysed reactions of amines with dimethyl carbonate (DMC) have been conducted with significant yields and selectivity of carboxymethylation or methylation products. Lewis acids (FeCl, ZnCl, and AlCl·6HO), Brønsted acids (PTSA, acetic, and formic acids), and acids supported on silica (silica sulfuric and silica perchlorate) resulted in carboxymethylation of primary aliphatic amines with high conversions. It was found that the Lewis acid FeCl also promoted carboxymethylation of primary aromatic amines and secondary amines.
View Article and Find Full Text PDF